Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder
Urologic Oncology: Seminars and Original Investigations, 10/26/09
Satyam A et al. – The results of the study delineate that in bladder tumor patients a marked polarization exists towards the expression of Th2 type cytokines while Th1 remain suppressed. Furthermore, the levels of all the cytokines alter according to the grades of the tumor. This can give significant insights about the use of Th1 type cytokines for the administration of immunotherapy to bladder cancer patients. Development of new strategies attempting to manipulate the equilibrium between Th1 and Th2 cells would be beneficial in the management of UC of bladder in future.
Related Articles
Dermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09
Relevance Score: 83%
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Relevance Score: 82%
192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09
Relevance Score: 82%
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09
Relevance Score: 82%
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09
Relevance Score: 82%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor
Cancer Immunology, Immunotherapy, 03/17/10
Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer
The Oncologist, 03/17/10
Current Management of Gallbladder Carcinoma
The Oncologist, 03/17/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
New treatments for chronic prostatitis/chronic pelvic pain syndrome
NCP Urology, 03/17/10
Diseases of the prostate
Reviews in Clinical Gerontology, 03/17/10
Anticholinergics for urge incontinence
Reviews in Clinical Gerontology, 03/17/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Growth inhibition of tumor cells in vitro by using monoclonal antibodies against gonadotropin-releasing hormone receptor
Cancer Immunology, Immunotherapy, 03/17/10
Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer
The Oncologist, 03/17/10
Current Management of Gallbladder Carcinoma
The Oncologist, 03/17/10
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
New treatments for chronic prostatitis/chronic pelvic pain syndrome
NCP Urology, 03/17/10
Anticholinergics for urge incontinence
Reviews in Clinical Gerontology, 03/17/10
Diseases of the prostate
Reviews in Clinical Gerontology, 03/17/10
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms
International Journal of Clinical Practice, 03/17/10
Subepithelial growth patterns in urothelial carcinoma—frequency and prognostic significance
Urologic Oncology: Seminars and Original Investigations, 03/17/10
Functional role of cannabinoid receptors in urinary bladder
Indian Journal of Urology, 03/17/10
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum IgG against Candida predict survival in patients with metastatic renal cell carcinoma
Cancer Immunology, Immunotherapy, 03/17/10
C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results
Urologic Oncology: Seminars and Original Investigations, 03/17/10
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy
Clinical Cancer Research, 03/17/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


